IEX •
Healthcare •
Biotechnology •
Quote as of 08/24/2026 15:59
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeIEX
Market Capitalization238.85 mln
Float17.03 mln
Earnings Date11/11/2026
1-Year Forecast
15.17
Transformational upside
Relative Strength
97
/ 100
Top performer
Debt / Equity
0.03
Debt-free
ROE
-32.06
Deeply negative
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
Sionna Therapeutics is a Waltham, Massachusetts-based medical company focused entirely on developing new treatments for cystic fibrosis. Founded in 2019, the company has built a pipeline of six drug candidates, each targeting different parts of the protein responsible for the disease, with several having already advanced through early and mid-stage clinical trials. Previously operating under the name Sling Therapeutics, the company rebranded in 2021 and continues to work toward better options for patients living with this serious condition.
